Solvay S.A.
Participation notification by Blackrock Inc.
Brussels, 8 March 2021, 08:30 CET - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notification indicating that it crossed the threshold of 3%.
| Date on which the threshold was crossed | Voting rights after the transaction | Equivalent financial instruments after the transaction | Total |
| March 2, 2021 | 2.90% | 0.18% | 3.08% |
The latest notification, dated March 3, 2021, contains the following information:
- Reason for the notification: acquisition or disposal of voting securities or voting rights
- Notified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)
- Date on which the threshold is crossed: March 2, 2021
- Threshold of direct voting rights crossed: 3% downwards
- Denominator: 105,876,416
- Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going below 3%.
Transparency notifications and the full chain of controlled undertakings through which the holding is effectively held is available on the Investor Relations Section of Solvay's website.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Modelo7.1.2026 15:00:00 CET | Press release
Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
Genmab A/S7.1.2026 15:00:00 CET | Press release
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
CNH Industrial N.V.7.1.2026 15:00:00 CET | Press release
AE50 2026: ASABE lists three Ag Tech innovations from CNH
BTCS, Inc.7.1.2026 14:30:00 CET | Press release
BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter
Egle Therapeutics7.1.2026 14:00:00 CET | Press release
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
